Transgene Market Cap

Transgene has a market cap or net worth of 68.93 million as of April 24, 2025. Its market cap has decreased by -44.53% in one year.

Market Cap

68.93M

Enterprise Value

63.57M

Revenue

5.25M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.62

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 98.01M to 68.93M, a decrease of -29.67%. That is a compound annual growth rate of -1.29%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	67.75M	-8.72%
Dec 31, 2024	74.22M	-37.92%
Dec 29, 2023	119.56M	-18.19%
Dec 30, 2022	146.14M	-29.80%
Dec 31, 2021	208.16M	68.48%
Dec 31, 2020	123.55M	13.08%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	157.23B
GSK plc	55.19B
Haleon	34.87B
Smith & Nephew	8.58B
ConvaTec Group	5.21B
Hikma Pharmaceuticals	4.15B
HUTCHMED (China)	2.01B
Oxford Nanopore Technologies	1.13B

Market Cap Rankings